NCT04853004 - Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations | Biotech Hunter

Enrollment

10,000

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

December 31, 2025

Conditions

SARS-CoV 2

Interventions

DIAGNOSTIC_TEST

SARS-CoV2 antibody measurement

Blood samples for serology, collected immediately prior to and five to ten weeks after vaccination against SARS-CoV2, to be analyzed for the presence of SARS-CoV-2 antibodies.

Trial Locations (1)

141 86

Karolinska University Hospital, Stockholm

All Listed Sponsors

collaborator

Karolinska University Hospital

OTHER

lead

Karolinska Institutet

OTHER